Commission Implementing Decision (EU) 2023/458 of 1 March 2023 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/decision/2023/458@2023-03-01/en
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products, and in particular Article 89(1), third subparagraph, thereof,
Whereas:
(1) Commission Delegated Regulation (EU) No 1062/2014 establishes in its Annex II a list of active substance/product-type combinations included in the review programme of existing active substances in biocidal products.
(2) For a number of active substance/product-type combinations included in that list, all the participants have withdrawn or are considered to have withdrawn their support in a timely manner.
(3) In accordance with Article 14(1) of Delegated Regulation (EU) No 1062/2014, the European Chemicals Agency published an open invitation to take over the role of participant for those active substance/product-type combinations for which the role of participant had not previously been taken over. For those combinations no notification has been submitted to the European Chemicals Agency within the time limit provided for by Article 14(2) of Delegated Regulation (EU) No 1062/2014. Therefore, those active substance/product-type combinations, in accordance with Article 20, first paragraph, point (b), of Delegated Regulation (EU) No 1062/2014, should not be approved for use in biocidal products.
(4) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Biocidal Products,
HAS ADOPTED THIS DECISION:
Article 1
The active substances listed in the Annex are not approved for the product-types indicated therein.
Article 2
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Done at Brussels, 1 March 2023. For the Commission The President Ursula von der Leyen
ANNEX
ANNEX
Active substance/product-type combinations not approved: Entry Number in Annex II to Regulation (EU) No 1062/2014 Substance name Rapporteur Member State EC number CAS number Product-type(s) 1022 Dialuminium chloride pentahydroxide NL 234-933-1 12042-91-0 2 691 Sodium N-(hydroxymethyl)glycinate AT 274-357-8 70161-44-3 6 459 Reaction mass of titanium dioxide and silver chloride SE Not available Not available 1, 2, 6, 7, 9, 10, 11 531 (benzyloxy)methanol AT 238-588-8 14548-60-8 13 1016 Silver chloride SE 232-033-3 7783-90-6 1 444 7a-ethyldihydro-1H,3H,5H-oxazolo[3,4-c]oxazole (EDHO) PL 231-810-4 7747-35-5 6, 13 797 cis-1-(3-chloroallyl)-3,5,7-triaza-1- azoniaadamantane chloride (cis CTAC) PL 426-020-3 51229-78-8 6, 13 368 Methenamine 3-chloroallylochloride (CTAC) PL 223-805-0 4080-31-3 6, 12, 13